CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr | ₹-18 Cr | ₹125 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-403 Cr |
Mar2023 | ₹-293 Cr |
Mar2022 | ₹-205 Cr |
Mar2021 | ₹-18 Cr |
Mar2020 | ₹125 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-403 Cr | Negative | |
Mar2023 | ₹-293 Cr | Negative | |
Mar2022 | ₹-205 Cr | Negative | |
Mar2021 | ₹-18 Cr | Negative | |
Mar2020 | ₹125 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹123,327.7 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.1% |
1.8% |
-1.6% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses